Anti-PD-1 CE/IVD for IHC - Hematopathology

Anti-PD-1 CE/IVD for IHC - Hematopathology

 
Programmed Death 1 (PD-1) is a member of the CD28/CTLA-4 family of T-cell regulators, expressed as a co-receptor on the surface of activated T-cells, B-cells, and macrophages. New studies have suggested that the PD-1/PD-L1 signaling pathway may be linked to anti-tumor immunity, as PD-L1 has been shown to induce apoptosis of activated T cells or inhibit activity of cytotoxic T cells. In comparison to CD10 and Bcl-6, PD-1 is expressed by fewer B cells and has therefore been considered a more specific and useful diagnostic marker for angioimmunoblastic T-cell lymphoma. Therapies targeted toward the PD-1 receptor have shown remarkable clinical responses in patients with various types of cancer, including non–small-cell lung cancer, melanoma, and renal-cell cancer.
 
 
 
Tonsil section
Tonsil section

 

Search result : 4 product found

Refine your search :

RUOCE / IVD
  • Unconjugated 4
  • human 4
  • Primary antibody
  • mouse 4
  • IHC 4
  • IHC001 3
  • JAD1 1
APPLY FILTERS
REINITIALIZE


Cat#
Description
Cond.
Price Bef. VAT
IHC001-1
 1ml,Concentrated 
IHC001-100
 0.1ml,Concentrated 
DIA-PD1-OD
 100µl